SANOFI PASTEUR S A has a total of 17 patent applications. Its first patent ever was published in 1998. It filed its patents most often in United States, Mexico and Costa Rica. Its main competitors in its focus markets pharmaceuticals, biotechnology and chemical engineering are OXXON THERAPEUTICS LTD, JAPAN AS REPRESENTED BY THE DIRECTOR GENERAL OF NAT INSTITUTE OF INFECTIOUS DISEASES and SAECHSISCHES SERUMWERK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | Mexico | 3 | |
#3 | Costa Rica | 1 | |
#4 | India | 1 | |
#5 | Singapore | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Chemical engineering | |
#4 | Environmental technology | |
#5 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Plitzko Matthias | 4 |
#2 | Luy Bernhard | 4 |
#3 | Struschka Manfred | 4 |
#4 | Bernhard Luy | 3 |
#5 | Manfred Struschka | 3 |
#6 | Matthias Plitzko | 3 |
#7 | Leroy Odile | 2 |
#8 | Martin Pierre | 1 |
#9 | Le Gros Francois-Xavier | 1 |
#10 | Hartmann Marcus | 1 |
Publication | Filing date | Title |
---|---|---|
US2010215692A1 | Dengue chimeric viruses | |
US2004228880A1 | Vaccine composition comprising iron phosphate as vaccine adjuvant |